腺苷5'-单磷酸通过降低线粒体代谢和氧需求在缺氧中提供保护
严重创伤或心脏骤停后的缺血再灌注损伤是ICU患者器官损伤的主要原因,脑组织因高度依赖氧化磷酸化而对缺氧尤为脆弱。治疗性低温可减轻缺血性脑损伤,但降温过程缓慢且在危重症环境中技术操作困难。既往报道注射天然存在的腺苷5'-单磷酸(AMP)可快速诱导小鼠低温。本研究探讨其机制,发现AMP可短暂降低成年雄性和雌性C57BL/6J小鼠的心率、呼吸频率、体温和意识,并在小鼠或人神经元细胞培养中剂量依赖性降低线粒体膜电位(ΔΨm)和钙信号。AMP处理增加细胞内AMP水平并激活AMP活化蛋白激酶,抑制mTORC1及静息和受刺激神经元的线粒体和胞质钙信号。与未处理小鼠相比,腹腔注射AMP预处理使小鼠在缺氧(6% O2)或无氧(<1% O2)条件下的存活时间几乎翻倍。作者认为这些发现提示AMP诱导低代谢状态,减慢线粒体呼吸、降低氧需求并延缓缺氧再灌注后脑和其他器官的线粒体损伤过程,进一步研究这些机制可能带来危重症患者器官功能保护的新治疗。
要点
- 腹腔注射AMP预处理使小鼠在缺氧(6% O2)或无氧(<1% O2)条件下的存活时间几乎翻倍,对照为未处理小鼠。
- AMP可短暂降低成年雄性和雌性C57BL/6J小鼠的心率、呼吸频率、体温和意识。
- AMP在小鼠或人神经元细胞培养中剂量依赖性降低线粒体膜电位(ΔΨm)和钙信号。
- AMP处理增加细胞内AMP水平并激活AMP活化蛋白激酶,抑制mTORC1及静息和受刺激神经元的线粒体和胞质钙信号。
- 作者认为AMP诱导的低代谢状态可能延缓缺氧再灌注后脑和其他器官的线粒体损伤,需进一步研究这些机制。
适用人群与场景
- 实验对象为成年雄性和雌性C57BL/6J小鼠,以及小鼠或人神经元细胞培养。
处置流程与药物剂量
- AMP经腹腔注射给药用于小鼠预处理,原文未报告具体剂量、浓度、给药频次或疗程。
研究设计与关键结果
- 研究类型为动物实验和细胞实验,对象为成年雄性和雌性C57BL/6J小鼠及小鼠或人神经元细胞培养,未报告样本量。
- AMP处理短暂降低小鼠心率、呼吸频率、体温和意识。
- AMP在小鼠或人神经元细胞培养中剂量依赖性降低线粒体膜电位(ΔΨm)和钙信号。
- AMP处理增加细胞内AMP水平并激活AMP活化蛋白激酶,抑制mTORC1及静息和受刺激神经元的线粒体和胞质钙信号。
- 与未处理小鼠相比,腹腔注射AMP预处理使小鼠在缺氧(6% O2)或无氧(<1% O2)条件下的存活时间几乎翻倍。
证据类型、等级与局限
- 证据类型为动物实验和细胞实验。
- 作者在结论中提出进一步检查这些机制可能带来危重症患者器官功能保护的新治疗。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出临床推荐;作者认为进一步研究这些机制可能带来危重症患者器官功能保护的新治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Ischemia and reperfusion injury following severe trauma or cardiac arrest are major causes of organ damage in intensive care patients. The brain is particularly vulnerable because hypoxia rapidly damages neurons due to their heavy reliance on oxidative phosphorylation. Therapeutic hypothermia can reduce ischemia-induced brain damage, but cooling procedures are slow and technically difficult to perform in critical care settings. It has been previously reported that injection of naturally occurring adenosine 5'-monophosphate (AMP) can rapidly induce hypothermia in mice. We studied the underlying mechanisms and found that AMP transiently reduces the heart rate, respiratory rate, body temperature, and the consciousness of adult male and female C57BL/6J mice. Adding AMP to mouse or human neuronal cell cultures dose-dependently reduced the membrane potential (ΔΨm) and Ca signaling of mitochondria in these cells. AMP treatment increased intracellular AMP levels and activated AMP-activated protein kinase, which resulted in the inhibition of mammalian target of rapamycin complex 1 (mTORC1) and of mitochondrial and cytosolic Ca signaling in resting and stimulated neurons. Pretreatment with an intraperitoneal injection of AMP almost doubled the survival time of mice under hypoxic (6% O2) or anoxic (<1% O2) conditions when compared to untreated mice. These findings suggest that AMP induces a hypometabolic state that slows mitochondrial respiration, reduces oxygen demand, and delays the processes that damage mitochondria in the brain and other organs following hypoxia and reperfusion. Further examination of these mechanisms may lead to new treatments that preserve organ function in critical care patients.
参考来源
- Kondo Y, Sueyoshi K, Zhang J, et al. Adenosine 5'-Monophosphate Protects from Hypoxia by Lowering Mitochondrial Metabolism and Oxygen Demand. Shock. 2020. PMID: 31460871. doi:10.1097/SHK.0000000000001440
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。